PPARGC1A and fatty liver disease: Moreover, it has been reported that p65 could interact with PGC-1α and inhibit its transcriptional activity, resulting in a decrease in the mitochondrial content and increase in hepatic steatosis in mice fed with HFDs (Zhou et al., 2013).